- Home
- MGIC vs HUMAW Comparison
MGIC vs HUMAW Comparison
Compare MGIC & HUMAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGIC
- HUMAW
- Stock Information
- Founded
- MGIC 1983
- HUMAW 2004
- Country
- MGIC Israel
- HUMAW United States
- Employees
- MGIC N/A
- HUMAW 220
- Industry
- MGIC Computer Software: Prepackaged Software
- HUMAW Biotechnology: Pharmaceutical Preparations
- Sector
- MGIC Technology
- HUMAW Health Care
- Exchange
- MGIC Nasdaq
- HUMAW Nasdaq
- Market Cap
- MGIC 1.0B
- HUMAW N/A
- IPO Year
- MGIC 1991
- HUMAW N/A
- Fundamental
- Price
- MGIC $20.43
- HUMAW $0.18
- Analyst Decision
- MGIC Buy
- HUMAW
- Analyst Count
- MGIC 2
- HUMAW 0
- Target Price
- MGIC $18.00
- HUMAW N/A
- AVG Volume (30 Days)
- MGIC 41.2K
- HUMAW 14.2K
- Earning Date
- MGIC 08-13-2025
- HUMAW 03-21-2025
- Dividend Yield
- MGIC 2.76%
- HUMAW N/A
- EPS Growth
- MGIC 16.93
- HUMAW N/A
- EPS
- MGIC 0.78
- HUMAW N/A
- Revenue
- MGIC $584,528,000.00
- HUMAW N/A
- Revenue This Year
- MGIC $11.11
- HUMAW N/A
- Revenue Next Year
- MGIC $6.83
- HUMAW N/A
- P/E Ratio
- MGIC $26.09
- HUMAW N/A
- Revenue Growth
- MGIC 11.98
- HUMAW N/A
- 52 Week Low
- MGIC $10.42
- HUMAW $1.18
- 52 Week High
- MGIC $22.00
- HUMAW $1.34
- Technical
- Relative Strength Index (RSI)
- MGIC 54.28
- HUMAW N/A
- Support Level
- MGIC $18.72
- HUMAW N/A
- Resistance Level
- MGIC $20.80
- HUMAW N/A
- Average True Range (ATR)
- MGIC 0.51
- HUMAW 0.00
- MACD
- MGIC 0.05
- HUMAW 0.00
- Stochastic Oscillator
- MGIC 78.08
- HUMAW 0.00
About MGIC Magic Software Enterprises Ltd.
Magic Software Enterprises Ltd is a software development company. The company's operating segment includes Software Services and IT Professional Services. The company generates maximum revenue from the IT Professional Services segment. IT Professional Services segment offers IT services in the areas of infrastructure design and delivery, application development, technology planning and implementation services, communications services and solutions, as well as supplemental outsourcing services. Geographically, it derives a majority of revenue from the United States and also has a presence in Israel, Europe, Japan, and Other countries.
About HUMAW Humacyte Inc. Warrant
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.